Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75533.76 1074.23 (1.44%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
31	Kopran Ltd.	Q V PT	1,156 Small Cap	243.05 (1.57%)	46.29	2.16	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Medicamen Biotech Ltd.	Q V+ PT	359 Small Cap	256.85 (0.53%)	33.18	1.26	11.90	-6.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	260.90 (1.08%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	263.40 (2.77%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Advanced Enzyme Technologies Ltd.	Q V+ PT	2,944 Small Cap	279.60 (6.33%)	29.56	4.15	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Artemis Medicare Services Ltd.	Q V PT	4,626 Small Cap	281.55 (-3.64%)	40.32	5.02	21.50	83.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Tarsons Products Ltd.	Q V+ PT	1,552 Small Cap	290.35 (-0.48%)	139.91	2.45	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Bajaj Healthcare Ltd.	Q V+ PT	1,031 Small Cap	307.90 (0.57%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310.05 (1.11%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Indraprastha Medical Corporation Ltd.	Q V PT	2,797 Small Cap	313.05 (2.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Suraksha Diagnostic Ltd.	Q V PT	1,653 Small Cap	325 (2.39%)	46.18	6.44	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Panacea Biotec Ltd.	Q V PT	1,917 Small Cap	325.25 (3.93%)	N/A	2.29	0.47	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Biocon Ltd.	Q V PT	57,365 Mid Cap	356.60 (1.31%)	587.16	2.1	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Ind-Swift Laboratories Ltd.	Q V+ PT	3,246 Small Cap	360.75 (-1.81%)	38.85	2.16	-6.14	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Gujarat Themis Biosyn Ltd.	Q V PT	4,718 Small Cap	369.80 (2.01%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	FDC Ltd.	Q V PT	6,132 Small Cap	380.70 (1.08%)	19.53	2.29	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Syngene International Ltd.	Q V+ PT	16,252 Small Cap	407.45 (1.20%)	76.91	3.44	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Fermenta Biotech Ltd.	Q V PT	1,229 Small Cap	420.30 (0.66%)	20.32	2.98	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Gufic Biosciences Ltd.	Q V PT	4,134 Small Cap	422.70 (2.55%)	56.27	6.01	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Aarti Drugs Ltd.	Q V PT	3,977 Small Cap	448.30 (2.89%)	20.8	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Cohance Lifesciences Ltd.	Q V+ PT	17,005 Small Cap	449.25 (1.08%)	160.07	4.42	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	One Global Service Provider Ltd.	Q V+ PT	854 Small Cap	456.80 (4.50%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	465.50 (1.86%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	488.30 (0.71%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Unichem Laboratories Ltd.	Q V PT	3,404 Small Cap	494 (2.18%)	11.17	1.24	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Amrutanjan Health Care Ltd.	Q V+ PT	1,436 Small Cap	497.10 (0.05%)	26.61	3.83	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	501.20 (-0.63%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Sai Parenterals Ltd.	Q V PT	2,302 Small Cap	503.85 (-3.29%)	139.47	2.95	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Lincoln Pharmaceuticals Ltd.	Q V PT	1,005 Small Cap	504.60 (0.53%)	10.38	1.24	9.61	3.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	SMS Pharmaceuticals Ltd.	Q V+ PT	4,793 Small Cap	505.35 (-1.25%)	46.8	5.95	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,189.65	-4.47%
Bliss GVS Pharma	624.10	-3.75%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Nov, 2026

Advanced Enzyme Tech - Quaterly Results

The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1371.68	1157.48	18.51	2530.25	2407.72	5.09	4527.66	3514.11	28.84
Other Income	163.97	30.79	432.54	186.84	569.31	-67.18	633.88	614.90	3.09
PBIDT	543.16	326.70	66.26	870.15	1170.48	-25.66	1738.22	1321.69	31.51
Interest	0.31	0.49	-36.73	0.68	1.02	-33.33	2.07	2.36	-12.29
PBDT	542.85	326.21	66.41	869.47	1169.46	-25.65	1697.57	1319.33	28.67
Depreciation	31.73	30.02	5.70	60.94	59.31	2.75	120.83	114.05	5.94
PBT	511.12	296.19	72.56	808.53	1110.15	-27.17	1576.74	1205.28	30.82
TAX	94.07	73.37	28.21	168.02	147.52	13.90	258.68	181.08	42.85
Deferred Tax	1.25	0.54	131.48	8.56	0.28	2957.14	-12.01	12.22	-198.28
PAT	417.05	222.82	87.17	640.51	962.63	-33.46	1318.06	1024.20	28.69
Equity	220.53	223.76	-1.44	223.95	223.76	0.08	223.85	223.76	0.04
PBIDTM(%)	39.60	28.23	40.29	34.39	48.61	-29.26	38.39	37.61	2.07

Oct, 2026

Advanced Enzyme Technologies informs about outcome of board meeting

Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Artemis Medicare Services informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Services has enclosed the copy of un-audited financial results for the quarter and half year ended September 30, 2026, published in the following newspapers on October 31, 2026: The Financial Express (English National Daily Newspaper- all editions); The Jansatta (Hindi National Daily Newspaper- Delhi edition). The aforesaid results are also accessible on the Company’s website at https://www.artemishospitals.com/investors.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Lincoln Pharmaceuticals informs about press release

Lincoln Pharmaceuticals has informed that it enclosed copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Gennex Laboratories Ltd.	195 Crore
2	Take Ltd.	159 Crore
3	Medico Remedies Ltd.	155 Crore
4	Syncom Formulations (India) Ltd.	1,810 Crore
5	Sigachi Industries Ltd.	1,009 Crore
6	Anlon Healthcare Ltd.	1,378 Crore
7	Fischer Medical Ventures Ltd.	1,729 Crore
8	Ambalal Sarabhai Enterprises Ltd.	268 Crore
9	Shukra Medtech Ltd.	3,317 Crore
10	Anuh Pharma Ltd.	873 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,373	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,666	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,238	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Advanced Enzyme Tech - Quaterly Results

Advanced Enzyme Technologies informs about outcome of board meeting

Artemis Medicare Services informs about newspaper publication

Vimta Labs - Quaterly Results

Vimta Labs informs about unaudited financial results

Lincoln Pharmaceuticals informs about press release

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?